drugset / Trial / NCT00585052
A Phase II Study of Interaction of Lovastatin and Paclitaxel For Patients With Refractory or Relapsed Ovarian Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to find out if the treatment combination of paclitaxel and lovastatin is more effective than the currently available chemotherapy for refractory or relapsed ovarian cancer. This research is being done to improve on currently available chemotherapy for ovarian cancer.
Timeline
- Start
- 2003-08
- Primary completion
- 2010-02
- Completion
- 2013-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lovastatin | Small molecule | 80 mg | Oral |
| Subject | Paclitaxel | Small molecule | 80 mg/m2 | Intravenous |